Mitophagy-dependent mitochondrial DNA release links ionizing radiation to immunogenic cell death in pancreatic cancer
Open Access
- 30 July 2026
- journal article
- research article
- Published by Springer Nature in Cell Death Discovery
- Vol. 12 (1)
Abstract
Ionizing radiation (IR) elicits both cytotoxic and immunomodulatory effects, yet the precise link between mitochondrial remodeling and immunogenic cell death (ICD) remains elusive. Here, we report that IR triggers robust mitophagy in pancreatic cancer cells, marked by mitochondrial damage, Parkin/BNIP3 upregulation, and increased autophagic flux. In parallel, IR induces key hallmarks of ICD, including calreticulin exposure, HMGB1 translocation, and the release of ATP and IFN-β. Notably, genetic or pharmacological inhibition of mitophagy attenuated this immunogenic profile, whereas mitophagy induction amplified it. We further demonstrate that mitophagy triggers the cytosolic release of mitochondrial DNA (mtDNA) to activate immune signaling, which can be reversed by blocking mtDNA replication. In murine models, Parkin overexpression enhanced mitophagy and ICD marker expression, leading to reduced tumor burden and prolonged survival following irradiation. Collectively, our findings indicate that mtDNA leakage downstream of mitophagy links mitochondrial remodeling to radiation-induced ICD, suggesting that modulation of mitochondrial dynamics may represent a strategy to enhance both radiosensitivity and the immunogenic potential of radiotherapy in pancreatic cancer.Keywords
This publication has 31 references indexed in Scilit:
- Cancer cell death: Cell-autonomous and immunogenic dimensionsCancer Cell, 2025
- Cytosolic DNA in radiotherapy: relevance, mechanisms, and detectionRadiotherapy and Oncology, 2025
- DAMPs in the immunogenicity of cell deathMolecular Cell, 2025
- Synthetic anticoagulant octaparin targets mitochondrial cardiolipin-GSDMD axis to rescue redox homeostasis in sepsisRedox Biology, 2025
- Mitophagy: A key regulator of radiotherapy resistance in the tumor immune microenvironmentMolecular Aspects of Medicine, 2025
- Mitochondria-targeted manganese-based mesoporous silica nanoplatforms trigger cGAS-STING activation and sensitize anti PD-L1 therapy in triple-negative breast cancerActa Biomaterialia, 2025
- Bridging clinical radiotherapy and space radiation therapeutics through reactive oxygen species (ROS)-triggered deliveryFree Radical Biology and Medicine, 2024
- HILPDA-mediated lipidomic remodelling promotes radiotherapy resistance in nasopharyngeal carcinoma by accelerating mitophagyCellular and Molecular Life Sciences, 2023
- Raddeanin A Enhances Mitochondrial DNA‐cGAS/STING Axis‐Mediated Antitumor Immunity by Targeting Transactive Responsive DNA‐Binding Protein 43Advanced Science, 2023
- Ionizing Radiation Triggers the Antitumor Immunity by Inducing Gasdermin E-Mediated Pyroptosis in Tumor CellsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2022